WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class

  • SAN DIEGO , May 19, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, all dates inclusive (the "Class Period"), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v.